Advertisement

Psychopharmacology

, Volume 208, Issue 3, pp 387–399 | Cite as

Blockade of serotonin 2A receptors prevents PCP-induced attentional performance deficit and CREB phosphorylation in the dorsal striatum of DBA/2 mice

  • Laura Pozzi
  • Barbara Greco
  • Giuseppina Sacchetti
  • Giampaolo Leoni
  • Roberto W. Invernizzi
  • Mirjana Carli
Original Investigation

Abstract

Rational and objective

Functional opposition between N-methyl-d-aspartate and 5-HT2A receptors may be a neural mechanism supporting cognitive functions. These systems converge on an intracellular signaling pathway that involves protein kinase A-dependent phosphorylation of different proteins including cyclic adenosine monophosphate response element binding (CREB). Thus, we tested whether selective 5-HT2A receptor antagonist, M100907, might abolish phencyclidine (PCP)-induced attentional performance deficit by preventing its effects on transduction mechanisms leading to CREB phosphorylation.

Methods

Using the five-choice serial reaction time task, the ability of subcutaneous injections of 2.5 and 10 µg/kg of M100907 to abolish the effects of an intraperitoneal injection of 1.5 mg/kg PCP on attentional performance as measured by accuracy (percentage of correct responses) and anticipatory and perseverative responding was assessed in DBA/2 mice. The effects of PCP, M100907, and their combination on S133-CREB and T34-DARPP32 phosphorylation in the dorsal striatum and prefrontal cortex (PFC) of behaviorally naïve mice were examined using Western blotting technique.

Results

PCP reduced accuracy and increased anticipatory and perseverative responses as well as it increased S133-CREB phosphorylation in the dorsal striatum but not in the PFC. Ten μg/kg M100907 abolished the PCP-induced attentional performance deficits and the increase in S133-CREB but not T34-DARPP32 phosphorylation. By itself, M100907 had no effect on attentional performance or phospho-S133-CREB and phospho-T34-DARPP32. Interestingly, the effect of PCP on phospho-S133-CREB but not on phospho-T34-DARPP32 was dependent on endogenous 5-HT.

Conclusions

The data indicate that blockade of 5-HT2A receptors may exert beneficial effects on cognitive deficits through a mechanism linked to striatal S133-CREB phosphorylation.

Keywords

M100907 Phencyclidine CREB DARPP32 Dorsal striatum Attention 

Notes

Acknowledgments

We thank Dr. S. Kongsamut (Aventis Pharmaceutical, USA) for the generous gift of M100907. Funding for these studies was provided by the Italian Ministry for University and Research (MIUR) grant RBAU01ZS5C. Supplementary information is available at the Psychopharmacology website.

Supplementary material

213_2009_1738_MOESM1_ESM.doc (608 kb)
ESM 1 (DOC 607 kb)

References

  1. Aghajanian GK, Marek GJ (2000) Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 31:302–312CrossRefPubMedGoogle Scholar
  2. Bakshi VP, Geyer MA (1997) Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist. J Pharmacol Exp Ther 283:666–674PubMedGoogle Scholar
  3. Barrot M, Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, Impey S, Storm DR, Neve RL, Yin JC, Zachariou V, Nestler EJ (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci USA 99:11435–11440CrossRefPubMedGoogle Scholar
  4. Baviera M, Invernizzi RW, Carli M (2008) Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC. Psychopharmacology (Berl) 196:269–280CrossRefGoogle Scholar
  5. Berkowitz LA, Gilman MZ (1990) Two distinct forms of active transcription factor CREB (cAMP response element binding protein). Proc Natl Acad Sci USA 87:5258–5262CrossRefPubMedGoogle Scholar
  6. Blendy JA, Kaestner KH, Schmid W, Gass P, Schutz G (1996) Targeting of the CREB gene leads to up-regulation of a novel CREB mRNA isoform. EMBO J 15:1098–1106PubMedGoogle Scholar
  7. Breier A, Malhotra AK, Pinals DA, Weisenfeld NI, Pickar D (1997) Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am J Psychiatry 154:805–811PubMedGoogle Scholar
  8. Calcagno E, Carli M, Invernizzi RW (2006) The 5-HT (1A) receptor agonist 8-OH-DPAT prevents prefrontocortical glutamate and serotonin release in response to blockade of cortical NMDA receptors. J Neurochem 96:853–860CrossRefPubMedGoogle Scholar
  9. Calcagno E, Carli M, Baviera M, Invernizzi RW (2009) Endogenous serotonin and serotonin2C receptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade. J Neurochem 108:521–532CrossRefPubMedGoogle Scholar
  10. Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ (1998) Regulation of cocaine reward by CREB. Science 282:2272–2275CrossRefPubMedGoogle Scholar
  11. Carli M, Samanin R (1992) Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats’ performance differently in a five-choice serial reaction time task. Psychopharmacology 106:228–234CrossRefPubMedGoogle Scholar
  12. Carli M, Robbins TW, Evenden JL, Everitt BJ (1983) Effects of lesions to ascending noradrenergic neurones on performance of a 5-choice serial reaction task in rats; implications for theories of dorsal noradrenergic bundle function based on selective attention and arousal. Behav Brain Res 9:361–380CrossRefPubMedGoogle Scholar
  13. Carli M, Baviera M, Invernizzi RW, Balducci C (2006) Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 31:757–767CrossRefPubMedGoogle Scholar
  14. Carli M, Pozzi L, Invernizzi R, Baviera M, Balducci C (2008) Activation of mGLU2/3 receptors inhibits the effects of NMDA receptor blockade in the mPFC on attentional performance and CREB-phosphorylation. #156.17 Society for Neuroscience Meeting, Washington, D.C.Google Scholar
  15. Ceglia I, Carli M, Baviera M, Renoldi G, Calcagno E, Invernizzi RW (2004) The 5-HT receptor antagonist M100, 907 prevents extracellular glutamate rising in response to NMDA receptor blockade in the mPFC. J Neurochem 91:189–199CrossRefPubMedGoogle Scholar
  16. Chalecka-Franaszek E, Chen H, Chuang DM (1999) 5-Hydroxytryptamine2A receptor stimulation induces activator protein-1 and cyclic AMP-responsive element binding with cyclic AMP-responsive element-binding protein and Jun D as common components in cerebellar neurons. Neuroscience 88:885–898CrossRefPubMedGoogle Scholar
  17. Chudasama Y, Robbins TW (2006) Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 73:19–38CrossRefPubMedGoogle Scholar
  18. Colombo PJ, Brightwell JJ, Countryman RA (2003) Cognitive strategy-specific increases in phosphorylated cAMP response element-binding protein and c-Fos in the hippocampus and dorsal striatum. J Neurosci 23:3547–3554PubMedGoogle Scholar
  19. Corbetta M, Miezin FM, Dobmeyer S, Shulman GL, Petersen SE (1991) Selective and divided attention during visual discriminations of shape, color, and speed: functional anatomy by positron emission tomography. J Neurosci 11:2383–2402PubMedGoogle Scholar
  20. Cornea-Hebert V, Riad M, Wu C, Singh SK, Descarries L (1999) Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat. J Comp Neurol 409:187–209CrossRefPubMedGoogle Scholar
  21. Dash PK, Karl KA, Colicos MA, Prywes R, Kandel ER (1991) cAMP response element-binding protein is activated by Ca2+/calmodulin- as well as cAMP-dependent protein kinase. Proc Natl Acad Sci USA 88:5061–5065CrossRefPubMedGoogle Scholar
  22. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P (1998) Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA 95:12202–12207CrossRefPubMedGoogle Scholar
  23. Enslen H, Sun P, Brickey D, Soderling SH, Klamo E, Soderling TR (1994) Characterization of Ca2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J Biol Chem 269:15520–15527PubMedGoogle Scholar
  24. Franko A, Mayer S, Thiel G, Mercy L, Arnould T, Hornig-Do HT, Wiesner RJ, Goffart S (2008) CREB-1alpha is recruited to and mediates upregulation of the cytochrome c promoter during enhanced mitochondrial biogenesis accompanying skeletal muscle differentiation. Mol Cell Biol 28:2446–2459CrossRefPubMedGoogle Scholar
  25. Gleason SD, Shannon HE (1997) Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice. Psychopharmacology (Berl) 129:79–84CrossRefGoogle Scholar
  26. Greco B, Invernizzi RW, Carli M (2005) Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU(2/3) receptor agonist LY379268. Psychopharmacology (Berl) 179:68–76CrossRefGoogle Scholar
  27. Harvey PD, Rabinowitz J, Eerdekens M, Davidson M (2005) Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trial. Am J Psychiatry 162:1888–1895CrossRefPubMedGoogle Scholar
  28. Harvey PD, Pappadopulos E, Lombardo I, Kremer CM (2009) Reduction of functional disability with atypical antipsychotic treatment: a randomized long term comparison of ziprasidone and haloperidol. Schizophr Res 115:24–29CrossRefPubMedGoogle Scholar
  29. Higgins GA, Enderlin M, Haman M, Fletcher PJ (2003) The 5-HT2A receptor antagonist M100, 907 attenuates motor and ‘impulsive-type’ behaviours produced by NMDA receptor antagonism. Psychopharmacology (Berl) 170:309–319CrossRefGoogle Scholar
  30. Holsztynska EJ, Weber WW, Domino EF (1991) Genetic polymorphism of cytochrome P-450-dependent phencyclidine hydroxylation in mice. Comparison of phencyclidine hydroxylation in humans. Drug Metab Dispos 19:48–53PubMedGoogle Scholar
  31. Impey S, Obrietan K, Storm DR (1999) Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron 23:11–14CrossRefPubMedGoogle Scholar
  32. Isles AR, Humby T, Walters E, Wilkinson LS (2004) Common genetic effects on variation in impulsivity and activity in mice. J Neurosci 24:6733–6740CrossRefPubMedGoogle Scholar
  33. Jakala P, Sirvio J, Jolkkonen J, Riekkinen P Jr, Acsady L, Riekkinen P (1992) The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behav Brain Res 51:29–40CrossRefPubMedGoogle Scholar
  34. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301–1308PubMedGoogle Scholar
  35. Kawanishi Y, Harada S, Tachikawa H, Okubo T, Shiraishi H (1999) Novel variants in the promoter region of the CREB gene in schizophrenic patients. J Hum Genet 44:428–430CrossRefPubMedGoogle Scholar
  36. Konradi C, Cole RL, Heckers S, Hyman SE (1994) Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J Neurosci 14:5623–5634PubMedGoogle Scholar
  37. Koskinen T, Ruotsalainen S, Puumala T, Lappalainen R, Koivisto E, Mannisto PT, Sirvio J (2000) Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology 39:471–481CrossRefPubMedGoogle Scholar
  38. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199–214PubMedGoogle Scholar
  39. Kyosseva SV, Elbein AD, Hutton TL, Griffin ST, Mrak RE, Sturner WQ, Karson CN (2000) Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor 2 in the cerebellar vermis of schizophrenic patients. Arch Gen Psychiatry 57:685–691CrossRefPubMedGoogle Scholar
  40. Le Pen G, Grottick AJ, Higgins GA, Moreau JL (2003) Phencyclidine exacerbates attentional deficits in a neurodevelopmental rat model of schizophrenia. Neuropsychopharmacology 28:1799–1809CrossRefPubMedGoogle Scholar
  41. Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B (2007) A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia. J Clin Psychiatry 68:368–379CrossRefPubMedGoogle Scholar
  42. Martin P, Waters N, Carlsson A, Carlsson ML (1997) The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication). J Neural Transm 104:561–564CrossRefPubMedGoogle Scholar
  43. Martin P, Carlsson ML, Hjorth S (1998) Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats. NeuroReport 9:2985–2988PubMedCrossRefGoogle Scholar
  44. Martin-Ruiz R, Puig MV, Celada P, Shapiro DA, Roth BL, Mengod G, Artigas F (2001) Control of serotonergic function in medial prefrontal cortex by serotonin-2A receptors through a glutamate-dependent mechanism. J Neurosci 21:9856–9866PubMedGoogle Scholar
  45. Mayr B, Montminy M (2001) Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2:599–609CrossRefPubMedGoogle Scholar
  46. Mirjana C, Baviera M, Invernizzi RW, Balducci C (2004) The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29:1637–1647CrossRefPubMedGoogle Scholar
  47. Miyamoto Y, Yamada K, Noda Y, Mori H, Mishina M, Nabeshima T (2001) Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit. J Neurosci 21:750–757PubMedGoogle Scholar
  48. Moghaddam B, Adams BW (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281:1349–1352CrossRefPubMedGoogle Scholar
  49. Muir JL, Everitt BJ, Robbins TW (1996) The cerebral cortex of the rat and visual attentional function: dissociable effects of mediofrontal, cingulate, anterior dorsolateral, and parietal cortex lesions on a five-choice serial reaction time task. Cereb Cortex 6:470–481CrossRefPubMedGoogle Scholar
  50. Murphy ER, Dalley JW, Robbins TW (2005) Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task. Psychopharmacology (Berl) 179:99–107CrossRefGoogle Scholar
  51. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119–128CrossRefPubMedGoogle Scholar
  52. Nibuya M, Nestler EJ, Duman RS (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16:2365–2372PubMedGoogle Scholar
  53. Nishi A, Watanabe Y, Higashi H, Tanaka M, Nairn AC, Greengard P (2005) Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc Natl Acad Sci USA 102:1199–1204CrossRefPubMedGoogle Scholar
  54. O'Callaghan JP, Sriram K (2004) Focused microwave irradiation of the brain preserves in vivo protein phosphorylation: comparison with other methods of sacrifice and analysis of multiple phosphoproteins. J Neurosci Methods 135:159–168CrossRefPubMedGoogle Scholar
  55. Owen AM (1997) Cognitive planning in humans: neuropsychological, neuroanatomical and neuropharmacological perspectives. Prog Neurobiol 53:431–450CrossRefPubMedGoogle Scholar
  56. Paine TA, Neve RL, Carlezon WA Jr (2009) Attention deficits and hyperactivity following inhibition of cAMP-dependent protein kinase within the medial prefrontal cortex of rats. Neuropsychopharmacology 34:2143–2155CrossRefPubMedGoogle Scholar
  57. Pham TA, Rubenstein JL, Silva AJ, Storm DR, Stryker MP (2001) The CRE/CREB pathway is transiently expressed in thalamic circuit development and contributes to refinement of retinogeniculate axons. Neuron 31:409–420CrossRefPubMedGoogle Scholar
  58. Pozzi L, Hakansson K, Usiello A, Borgkvist A, Lindskog M, Greengard P, Fisone G (2003) Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum. J Neurochem 86:451–459CrossRefPubMedGoogle Scholar
  59. Robbins TW, Everitt BJ (2002) Limbic–striatal memory systems and drug addiction. Neurobiol Learn Mem 78:625–636CrossRefPubMedGoogle Scholar
  60. Rogers RD, Baunez C, Everitt BJ, Robbins TW (2001) Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behav Neurosci 115:799–811CrossRefPubMedGoogle Scholar
  61. Scruggs JL, Patel S, Bubser M, Deutch AY (2000) DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J Neurosci 20:8846–8852PubMedGoogle Scholar
  62. Sheng M, Thompson MA, Greenberg ME (1991) CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252:1427–1430CrossRefPubMedGoogle Scholar
  63. Snyder GL, Galdi S, Hendrick JP, Hemmings HC Jr (2007) General anesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo. Neuropharmacology 53:619–630CrossRefPubMedGoogle Scholar
  64. Svenningsson P, Tzavara ET, Carruthers R, Rachleff I, Wattler S, Nehls M, McKinzie DL, Fienberg AA, Nomikos GG, Greengard P (2003) Diverse psychotomimetics act through a common signaling pathway. Science 302:1412–1415CrossRefPubMedGoogle Scholar
  65. Vanhoutte P, Barnier JV, Guibert B, Pages C, Besson MJ, Hipskind RA, Caboche J (1999) Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol Cell Biol 19:136–146PubMedGoogle Scholar
  66. Whitton PS, Biggs CS, Pearce BR, Fowler LJ (1992) MK-801 increases extracellular 5-hydroxytryptamine in rat hippocampus and striatum in vivo. J Neurochem 58:1573–1575CrossRefPubMedGoogle Scholar
  67. Winstanley CA, Chudasama Y, Dalley JW, Theobald DE, Glennon JC, Robbins TW (2003) Intra-prefrontal 8-OH-DPAT and M100907 improve visuospatial attention and decrease impulsivity on the five-choice serial reaction time task in rats. Psychopharmacology (Berl) 167:304–314Google Scholar
  68. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, Robbins TW (2004) 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl) 176:376–385CrossRefGoogle Scholar
  69. Yamamoto-Sasaki M, Ozawa H, Saito T, Rosler M, Riederer P (1999) Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res 824:300–303CrossRefPubMedGoogle Scholar
  70. Yin JC, Tully T (1996) CREB and the formation of long-term memory. Curr Opin Neurobiol 6:264–268CrossRefPubMedGoogle Scholar
  71. Yin HH, Knowlton BJ, Balleine BW (2004) Lesions of dorsolateral striatum preserve outcome expectancy but disrupt habit formation in instrumental learning. Eur J NeuroSci 19:181–189CrossRefPubMedGoogle Scholar
  72. Yin HH, Ostlund SB, Knowlton BJ, Balleine BW (2005) The role of the dorsomedial striatum in instrumental conditioning. Eur J NeuroSci 22:513–523CrossRefPubMedGoogle Scholar
  73. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG (2004) Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 305:217CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Laura Pozzi
    • 1
  • Barbara Greco
    • 1
    • 2
  • Giuseppina Sacchetti
    • 1
  • Giampaolo Leoni
    • 1
    • 3
  • Roberto W. Invernizzi
    • 1
  • Mirjana Carli
    • 1
  1. 1.Laboratory of Neurochemistry and Behavior, Department of NeuroscienceIstituto di Ricerche Farmacologiche “Mario Negri”MilanItaly
  2. 2.Department of Neuroscience and Brain TechnologiesIstituto Italiano di TecnologiaGenovaItaly
  3. 3.Università di Milano Bicocca, Biotecnologie e BioscienzeMilanoItaly

Personalised recommendations